HH

HJ Hong

Investor @Takeoff Capital || Strategic Advisor @EarnDLT

New York, New York

Invests in

  • Min Investment:

    $200,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $5,100,000.00

Work Experience

  • Investor

    2022

    Working closely with Equipmentshare (YC W15) Deals: • Reconstruct (Series B) • Branch Technology (Series B) • Flexbase (Seed) • Soil Connect (Seed) • Albiware (Seed/Series A) *hj@takeoffcap.com

2021

  • Chief of Staff

    2023

  • Strategic Advisor

    2021

    Series A

2021

  • Investor

    2021

  • Investor

    2020

  • Investor

    2019

  • Investor

    2021

2019 - 2022

  • Investor

    2019 - 2022

    Seed-Series B B2B-focused VC with $250M AUM from MIT (2008). Deals: Scope AR (Series A) *hhong@romuluscap.com

  • Capital Markets

    2021 - 2021

    REPE with ~$49B AUM *huckjun.hong@bridgeig.com

  • Chief of Tetrodotoxin Antitumoral Research

    2018 - 2021

    Publications: 1. Hong, H.J., Ly, S.Y. Voltammetric Detection of Tetrodotoxin Real-time In Vivo of Mouse Organs using DNA-immobilized Carbon Nanotube Sensors, Curr. Anal. Chem. 14 (2018) in print. 2. Hong, H.J., Ly, S.Y. Modified Synthesis of Tetrodotoxin and Novel Toxicity Diagnostic Sensors, Sensor Lett. 15 (2017) 557–564. 3. Ly, S.Y., Kim, Y.C., Hong, H.J., Kim, J., and Lee, K. Rapid Voltammetric Diagnosis of Escherichia Coli Contamination in Non-Treated Human Blood Plasma of Healthy and Sepsis-Infected Patients, IEEE Sensors Journal 18 (2018) 2200–2205. 4. Yoon, D.W. et al. Sleep Fragmentation Induces Activation of NOD-Like Receptor Protein-3 Inflammasome in Rat Hippocampus, Sleep Med. Res. 8 (2017) 26–32.

2020 - 2020

  • Columbia Chapter Co-Founder

    2020 - 2020